The Electroencephalogram (EEG) Disposable Medical Electrodes segmentation by application is dominated by three distinct use‑cases. Clinical Diagnosis accounts for roughly 55 % of total revenue, driven by hospital‑based neuro‑monitoring for epilepsy, sleep‑disordered breathing, and intensive‑care assessments where rapid electrode turnover is essential for infection control. Research & Development contributes about 30 % of the market; academic labs and pharmaceutical trials require high‑precision, low‑impedance disposable electrodes to ensure data integrity across repeated subject testing, prompting frequent repurchasing cycles. The remaining 15 % stems from Home Monitoring, a growing niche enabled by portable EEG platforms for chronic disease management and tele‑medicine follow‑up, where patient‑friendly, single‑use electrodes reduce training demands and contamination risk. Collectively, these applications shape the overall market size by aligning procurement volume with the clinical urgency, regulatory environment, and adoption of remote health technologies, establishing a clear hierarchy of demand across the EEG ecosystem.